Celularity debuts to develop placenta-based cell therapies

Celularity Inc. (Warren, N.J.) launched with an undisclosed series A round, as well as assets and IP, from Sorrento Therapeutics Inc. (NASDAQ:SRNE), United Therapeutics Corp. (NASDAQ:UTHR), Human Longevity Inc. (San Diego, Calif.) and additional undisclosed investors.

The newco is developing placenta-derived cell therapies to treat cancer and chronic and degenerative diseases...